Table 5.
The first test group includes patients suffering from chronic kidney disease (CKD).
| Characteristic | Avg ± SD |
|---|---|
| Age (years) | 66.71 ± 13.04 |
| Weight (kg) | 67.09 ± 18.93 |
| BMI (kg/m2) | 23.97 ± 6.39 |
| Ca (mg/dL) | 8.664 ± 1.36 |
| I PHOS (mg/dL) | 5.395 ± 1.16 |
| iPTH (pg/mL) | 1058.57 ± 842.62 |
| CREA (mg/dL) | 5.72 ± 1.53 |
| HGB (g/dL) | 10.76 ± 1.04 |
| %TSAT (%) | 27.92 ± 14.69 |
| FER (ug/L) | 839.75 ± 645.03 |
| ALB (g/L) | 36.92 ± 4.06 |
| K (mEq/L) | 5.446 ± 0.65 |
| Time of treatment (months) | 52.125 ± 46.64 |
| Body surface (m2) | 1.705 ± 0.22 |
| Kt/V | 1.788 ± 0.33 |
| Clearance (mL/min) | 236.11 ± 43.23 |
| nPCR (g/kg/day) | 1.077 ± 0.26 |
| Ca x P (mg2/dL2) | 46.875 ± 10.21 |